Geneos Wealth Management’s AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF SIXP Stock Holding History

Geneos Wealth Management’s Portfolio SIXP Stock Details SIXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$17.1K	Hold	548	–	–	﹤0.01%	1826
2025 Q4	$17.3K	Sell	548 -238	-30%	-$7.4K	﹤0.01%	1782
2025 Q3	$24.2K	Buy	+786	New	+$23.6K	﹤0.01%	1653

Other funds holding SIXP

Allianz Munich, Germany $9.02B AUM 28.63% 1-Year Est. Return

AWA

Authentikos Wealth Advisory Morgan Hill, California $148M AUM 9.86% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

BCM

Beck Capital Management Austin, Texas $437M AUM 59.35% 1-Year Est. Return

PFGIA

Patriot Financial Group Insurance Agency Westborough, Massachusetts $974M AUM 29.77% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

FCM

Fortis Capital Management Bellevue, Washington $977M AUM 17.17% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

Geneos Wealth Management's SIXP Position: Q1 2026 in Review

Geneos Wealth Management held its AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF (SIXP) position steady in Q1 2026 at 548 shares worth $17.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1826.

Geneos Wealth Management first reported a position in SIXP in Q3 2025 and has held it in 3 quarters since. The position peaked at $24.2K in Q3 2025. 31 funds tracked by Wall St. Rank hold SIXP as of Q1 2026.

Geneos Wealth Management held 548 shares of AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF worth $17.1K as of Q1 2026.
Geneos Wealth Management left its AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF share count unchanged in Q1 2026.
AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #1826 holding.
Geneos Wealth Management first reported a position in AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF in Q3 2025 and has held it in 3 quarters since.
Geneos Wealth Management's AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF position peaked at $24.2K in Q3 2025.
31 funds tracked by Wall St. Rank held AllianzIM U.S. Equity 6 Month Buffer10 Mar/Sep ETF as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.